DUSA Pharmaceuticals, Inc.®, a dermatology company that is developing and marketing Levulan® photodynamic therapy and other products targeting patients with common skin conditions, today reported financial results for the fourth quarter and full year ended December 31, 2006.
From: biz.yahoo.com
DUSA Pharmaceuticals Reports Fourth-Quarter and Year-End 2006 Financial Results
Posted by Ruslan Abuzant at 4:19 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment